Literature DB >> 6273010

Limitation of experimental infarct size by an angiotensin-converting enzyme inhibitor.

G Ertl, R A Kloner, R W Alexander, E Braunwald.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6273010     DOI: 10.1161/01.cir.65.1.40

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  39 in total

Review 1.  Role of bradykinin in preconditioning and protection of the ischaemic myocardium.

Authors:  G F Baxter; Z Ebrahim
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

2.  Imidapril treatment improves the attenuated inotropic and intracellular calcium responses to ATP in heart failure due to myocardial infarction.

Authors:  Harjot K Saini; Qiming Shao; Sorin Musat; Nobuakira Takeda; Paramjit S Tappia; Naranjan S Dhalla
Journal:  Br J Pharmacol       Date:  2005-01       Impact factor: 8.739

Review 3.  Tissue and plasma angiotensin converting enzyme and the response to ACE inhibitor drugs.

Authors:  R J MacFadyen; K R Lees; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

4.  Factors determining heterogeneity in coronary collateral development: A clinical perspective.

Authors:  Pier D Lambiase; Michael S Marber
Journal:  Exp Clin Cardiol       Date:  2002

5.  Does bradykinin play a role in the cardiac antiischemic effect of the ACE-inhibitors?

Authors:  P A Martorana; W Linz; B A Schölkens
Journal:  Basic Res Cardiol       Date:  1991 Jul-Aug       Impact factor: 17.165

Review 6.  Angiotensin converting enzyme inhibitors in angina and myocardial infarction. What role will they play in the 1990s?

Authors:  G Ertl
Journal:  Drugs       Date:  1993-08       Impact factor: 9.546

Review 7.  The renin-angiotensin system and coronary vasomotion.

Authors:  G Ertl; K Hu; W R Bauer; B Bauer
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

8.  Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).

Authors:  D W Cushman; F L Wang; W C Fung; G J Grover; C M Harvey; R J Scalese; S L Mitch; J M DeForrest
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

9.  Comparison of the effects of EXP3174, an angiotensin II antagonist and enalaprilat on myocardial infarct size in anaesthetized dogs.

Authors:  V Richard; B Ghaleh; A Berdeaux; J F Giudicelli
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

Review 10.  Aspects of molecular biology and biochemistry of the cardiac renin-angiotensin system.

Authors:  K Lindpaintner; M Jin; M Wilhelm; M Toth; D Ganten
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.